COVID-19 and age-related macular degeneration (AMD)
We are still learning how the coronavirus affects our health, and in particular our eye health. However, our knowledge is rapidly improving with the recent breakthrough of the potentially effective Pfizer vaccine. In this article, Mr Praveen Patel illustrates how the COVID-19 pandemic has presented a unique challenge to age-related macular degeneration (AMD) patients and how they can continue caring for their eye health during these tough times.











